Published in Med Educ on March 01, 1990
Intellectual aptitude tests and A levels for selecting UK school leaver entrants for medical school. BMJ (2005) 4.89
Can we improve on how we select medical students? J R Soc Med (2002) 1.49
Correlation of preadmission organic chemistry courses and academic performance in biochemistry at a midwest chiropractic doctoral program. J Chiropr Educ (2010) 1.18
Chemistry courses as the turning point for premedical students. Adv Health Sci Educ Theory Pract (2009) 0.79
Selection of medical students and its implication for students at king faisal university. J Family Community Med (2005) 0.75
Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother (1990) 8.42
Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother (2003) 7.09
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64
A simple system for the presumptive identification of Candida albicans and differentiation of strains within the species. Sabouraudia (1980) 5.47
Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev (2001) 4.49
Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis (1997) 3.86
Molecular mechanisms of drug resistance in fungi. Trends Microbiol (1994) 3.55
NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J (2001) 3.48
Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole. J Clin Microbiol (1996) 3.42
Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother (1992) 3.23
Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology (1999) 3.19
Laboratory evaluation of antifungal agents: a comparative study of five imidazole derivatives of clinical importance. J Antimicrob Chemother (1980) 3.03
Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J Clin Microbiol (1992) 2.98
Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis (1999) 2.96
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol (2006) 2.86
Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. Br Med J (Clin Res Ed) (1985) 2.74
Modification and extension of tests for differentiation of Candida species and strains. Sabouraudia (1983) 2.68
Problems in the laboratory assessment of antifungal activity. Postgrad Med J (1979) 2.43
A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect Immun (1997) 2.35
Analysis of Candida albicans phenotypes from different geographical and anatomical sources. J Clin Microbiol (1983) 2.33
Mechanisms and clinical impact of antifungal drug resistance. J Med Vet Mycol (1994) 2.32
Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype. Rev Infect Dis (1990) 2.30
Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro. Antimicrob Agents Chemother (1982) 2.28
Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother (1997) 2.27
Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus. Antimicrob Agents Chemother (2003) 2.27
Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect Immun (1997) 2.24
Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J Gen Microbiol (1983) 2.18
Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis. J Med Microbiol (1980) 2.17
Collaborative consensus for optimized multilocus sequence typing of Candida albicans. J Clin Microbiol (2003) 2.17
An examination of the production of hydrolytic enzymes and toxins by pathogenic strains of Candida albicans. J Gen Microbiol (1971) 2.10
Genital candidosis. Clin Exp Dermatol (1982) 2.00
Candida infections in AIDS patients. Int J STD AIDS (1992) 1.98
The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole. J Antimicrob Chemother (1980) 1.75
New targets and delivery systems for antifungal therapy. Med Mycol (2000) 1.65
Morphogenesis in Candida albicans. Crit Rev Microbiol (1985) 1.65
Multilocus sequence typing of the pathogenic fungus Aspergillus fumigatus. J Clin Microbiol (2007) 1.65
Sequence of the Candida albicans gene encoding the secretory aspartate proteinase. J Med Vet Mycol (1991) 1.61
Relative inhibition factors--a novel approach to the assessment of antifungal antibiotics in vitro. J Antimicrob Chemother (1984) 1.54
Improved method for estimation of azole antifungal inhibitory concentrations against Candida species, based on azole/antibiotic interactions. J Med Vet Mycol (1986) 1.48
Relevance of antigenicity of Candida albicans growth phases to diagnosis of systemic candidiasis. Br Med J (1973) 1.47
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol (1996) 1.45
Candida albicans strain types from the genitalia of patients with and without Candida infection. Eur J Obstet Gynecol Reprod Biol (1983) 1.40
Candida albicans proteinase as a virulence factor in the pathogenesis of Candida infections. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 1.40
A morphology index for characterization of cell shape in Candida albicans. J Gen Microbiol (1989) 1.40
Prevalence of pathogenic yeasts and humoral antibodies to candida in diabetic patients. J Clin Pathol (1978) 1.38
Molecular analysis of CaMnt1p, a mannosyl transferase important for adhesion and virulence of Candida albicans. Proc Natl Acad Sci U S A (1998) 1.36
Biotyping of medically important fungi. Curr Top Med Mycol (1985) 1.35
Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro. J Antimicrob Chemother (1986) 1.29
The effect of growth medium of filament production in Candida albicans. Sabouraudia (1974) 1.27
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents. J Antimicrob Chemother (1984) 1.26
Enzyme activities associated with carbohydrate synthesis and breakdown in the yeast and mycelial forms of Candida albicans. J Gen Microbiol (1973) 1.26
Epidemiology of vaginal Candida infection: significance of numbers of vaginal yeasts and their biotypes. Eur J Obstet Gynecol Reprod Biol (1987) 1.25
Optimum conditions for initiation of filamentation in Candida albicans. Can J Microbiol (1975) 1.22
Control of an outbreak of systemic Candida albicans. Br Med J (Clin Res Ed) (1985) 1.19
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae. J Gen Microbiol (1985) 1.16
Binding of plasma proteins to Candida species in vitro. J Gen Microbiol (1988) 1.14
Susceptibility testing of pathogenic fungi with itraconazole: a process analysis of test variables. J Antimicrob Chemother (2001) 1.14
Identification of Candida glabrata by a 30-second trehalase test. J Clin Microbiol (2002) 1.11
Purified Candida albicans proteinase in the serological diagnosis of systemic candidosis. JAMA (1980) 1.09
Disseminated Candida infection syndrome in heroin addicts--dominance of a single Candida albicans biotype. J Med Microbiol (1987) 1.09
Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes. Antimicrob Agents Chemother (1997) 1.06
Detection of Candida precipitins. a comparison of double diffusion and counter immunoelectrophoresis. J Immunol Methods (1975) 1.02
Interactions of Candida albicans yeast cells, germ tubes and hyphae with human polymorphonuclear leucocytes in vitro. J Gen Microbiol (1984) 1.02
The variability of creatinine excretion in normal subjects, mental patients and pregnant women. Clin Chim Acta (1969) 1.01
Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis model. Chemotherapy (1985) 1.00
Non-identity and authentication of two major reference strains of Candida albicans. J Med Vet Mycol (1991) 1.00
Expression of an epitope by surface glycoproteins of Candida albicans. Variability among species, strains and yeast cells of the genus Candida. J Med Vet Mycol (1990) 0.99
Purification and properties of a glycoprotein acid phosphatase from Candida albicans. J Bacteriol (1973) 0.97
Distribution of pathogenic yeasts and humoral antibodies to candida among hospital inpatients. J Clin Pathol (1980) 0.97
Systemic candidiasis in Spanish heroin addicts: a possible source of infection. J Infect Dis (1987) 0.96
Adherence of Candida albicans to vaginal epithelia: significance of morphological form and effect of ketoconazole. Mykosen (1985) 0.93
Colony variations in Candida species. Mycoses (1989) 0.92
Candida albicans GRX2, encoding a putative glutaredoxin, is required for virulence in a murine model. Genet Mol Res (2007) 0.91
Peptones and mycological reproducibility. Sabouraudia (1978) 0.91
Demonstration of a septal pore in budding Candida albicans yeast cells. Sabouraudia (1984) 0.91
Ecology and epidemiology of Candida species. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 0.89
Chitinase levels in guinea pig blood are increased after systemic infection with Aspergillus fumigatus. Glycobiology (1996) 0.89
European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect (2011) 0.87
Expansion of the Candida albicans cell envelope in different morphological forms of the fungus. J Gen Microbiol (1992) 0.86
Cross-sectional study of oral Candida carriage in a human immunodeficiency virus (HIV)-seropositive population: predisposing factors, epidemiology and antifungal susceptibility. Mycoses (1998) 0.86
Characterization of Candida isolates from pediatric burn patients. J Clin Microbiol (1988) 0.86
Effect of chitinase complex on the antigenicity and chemistry of yeast-form cell walls and other fractions of Histoplasma capsulatum and Blastomyces dermatitidis. Sabouraudia (1974) 0.85
Growth of pathogenic Candida isolates anaerobically and under elevated concentrations of CO2 in air. J Med Vet Mycol (1987) 0.84
Pathogenesis of invasive candidiasis. J Med Vet Mycol (1994) 0.84
Persistence of miconazole in vaginal secretions after single applications. Implications for the treatment of vaginal candidosis. Br J Vener Dis (1981) 0.82
[Identification, cloning and characterization of the gene for the secretory aspartate protease of Candida albicans]. Mycoses (1991) 0.82
Single allele knock-out of Candida albicans CGT1 leads to unexpected resistance to hygromycin B and elevated temperature. Microbiology (2000) 0.81
Effects of itraconazole on phagocytosis and killing of Candida glabrata by polymorphonuclear leucocytes from guinea pigs. J Antimicrob Chemother (1992) 0.81
Distribution of chitinase in guinea pig tissues and increases in levels of this enzyme after systemic infection with Aspergillus fumigatus. Microbiology (1999) 0.81
Development of Candida albicans hyphae in different growth media--variations in growth rates, cell dimensions and timing of morphogenetic events. J Gen Microbiol (1986) 0.81
Reaction of Candida albicans cells of different morphology index with monoclonal antibodies specific for the hyphal form. J Med Microbiol (1991) 0.81
Functional aspects of secreted Candida proteinases. Adv Exp Med Biol (1998) 0.80
Abrogation by glucose of the ATP suppression induced by miconazole in Candida albicans. J Antimicrob Chemother (1989) 0.80
Finger nails as a reservoir for Candida albicans in recurrence of vaginal candidosis. Genitourin Med (1986) 0.79
Commercial kits for yeast identification: concerns for standardisation. Eur J Clin Microbiol Infect Dis (2001) 0.79
Resistance of the Candida albicans filamentous cycle to environmental change. Sabouraudia (1975) 0.79
Arthritis without grains caused by Pseudallescheria boydii. Mycoses (1996) 0.78
[Predominance of Candida albicans serotype A, biotype 15 3/7 in outbreaks of disseminated candidiasis in heroin addicts in Spain]. Med Clin (Barc) (1987) 0.78